MedWatch

GN Hearing: We are uniquely positioned in the OTC channel

GN Hearing has unveiled its imminent US launch plans for its hybrid hearing aid, which is prepared for when the upcoming OTC channel opens in the US, having already received a 510(k) approval by the US health authority.

Photo: GN Store Nord / PR

On Tuesday, GN Hearing announced that Jabra Enhance Plus, which is a hybrid between a true wireless earbud and a hearing aid, will be launched at the end of February.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs